Literature DB >> 29498847

Copper-Catalyzed Chan-Lam Cyclopropylation of Phenols and Azaheterocycles.

Joseph Derosa1, Miriam L O'Duill1, Matthew Holcomb1, Mark N Boulous1, Ryan L Patman2, Fen Wang2, Michelle Tran-Dubé2, Indrawan McAlpine2, Keary M Engle1.   

Abstract

Small molecules containing cyclopropane-heteroatom linkages are commonly needed in medicinal chemistry campaigns yet are problematic to prepare using existing methods. To address this issue, a scalable Chan-Lam cyclopropylation reaction using potassium cyclopropyl trifluoroborate has been developed. With phenol nucleophiles, the reaction effects O-cyclopropylation, whereas with 2-pyridones, 2-hydroxybenzimidazoles, and 2-aminopyridines the reaction brings about N-cyclopropylation. The transformation is catalyzed by Cu(OAc)2 and 1,10-phenanthroline and employs 1 atm of O2 as the terminal oxidant. This method is operationally convenient to perform and provides a simple, strategic disconnection toward the synthesis of cyclopropyl aryl ethers and cyclopropyl amine derivatives bearing an array of functional groups.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29498847      PMCID: PMC6003411          DOI: 10.1021/acs.joc.7b03100

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  32 in total

1.  Extraction of tacit knowledge from large ADME data sets via pairwise analysis.

Authors:  Christopher E Keefer; George Chang; Gregory W Kauffman
Journal:  Bioorg Med Chem       Date:  2011-05-06       Impact factor: 3.641

2.  Copper(II)-catalyzed ether synthesis from aliphatic alcohols and potassium organotrifluoroborate salts.

Authors:  Tan D Quach; Robert A Batey
Journal:  Org Lett       Date:  2003-04-17       Impact factor: 6.005

Review 3.  Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.

Authors:  Nicholas A Meanwell
Journal:  Chem Res Toxicol       Date:  2016-03-14       Impact factor: 3.739

4.  Evaluating the differences in cycloalkyl ether metabolism using the design parameter "lipophilic metabolism efficiency" (LipMetE) and a matched molecular pairs analysis.

Authors:  Antonia F Stepan; Gregory W Kauffman; Christopher E Keefer; Patrick R Verhoest; Martin Edwards
Journal:  J Med Chem       Date:  2013-08-21       Impact factor: 7.446

5.  Novel Ferroptosis Inhibitors with Improved Potency and ADME Properties.

Authors:  Sam Hofmans; Tom Vanden Berghe; Lars Devisscher; Behrouz Hassannia; Sophie Lyssens; Jurgen Joossens; Pieter Van Der Veken; Peter Vandenabeele; Koen Augustyns
Journal:  J Med Chem       Date:  2016-02-08       Impact factor: 7.446

6.  Aerobic Copper-Catalyzed O-Methylation with Methylboronic Acid.

Authors:  Clare E Jacobson; Noelia Martinez-Muñoz; David J Gorin
Journal:  J Org Chem       Date:  2015-07-07       Impact factor: 4.354

7.  Substituent effects on the rate constants for the photo-Claisen rearrangement of allyl aryl ethers.

Authors:  Alexandra L Pincock; James A Pincock; Roumiana Stefanova
Journal:  J Am Chem Soc       Date:  2002-08-21       Impact factor: 15.419

8.  Selective formation of secondary amides via the copper-catalyzed cross-coupling of alkylboronic acids with primary amides.

Authors:  Steven A Rossi; Kirk W Shimkin; Qun Xu; Luis M Mori-Quiroz; Donald A Watson
Journal:  Org Lett       Date:  2013-04-23       Impact factor: 6.005

9.  Kinetic and Spectroscopic Studies of Aerobic Copper(II)-Catalyzed Methoxylation of Arylboronic Esters and Insights into Aryl Transmetalation to Copper(II).

Authors:  Amanda E King; Bradford L Ryland; Thomas C Brunold; Shannon S Stahl
Journal:  Organometallics       Date:  2012-08-24       Impact factor: 3.876

10.  The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules.

Authors:  Tanaji T Talele
Journal:  J Med Chem       Date:  2016-06-30       Impact factor: 7.446

View more
  3 in total

1.  Cu-Catalyzed Hydroboration of Benzylidenecyclopropanes: Reaction Optimization, (Hetero)Aryl Scope, and Origins of Pathway Selectivity.

Authors:  Jose M Medina; Taeho Kang; Tuğçe G Erbay; Huiling Shao; Gary M Gallego; Shouliang Yang; Michelle Tran-Dubé; Paul F Richardson; Joseph Derosa; Ryan T Helsel; Ryan L Patman; Fen Wang; Christopher P Ashcroft; John F Braganza; Indrawan McAlpine; Peng Liu; Keary M Engle
Journal:  ACS Catal       Date:  2019-10-29       Impact factor: 13.084

2.  A General N-alkylation Platform via Copper Metallaphotoredox and Silyl Radical Activation of Alkyl Halides.

Authors:  Nathan W Dow; Albert Cabré; David W C MacMillan
Journal:  Chem       Date:  2021-06-16       Impact factor: 25.832

3.  Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors.

Authors:  Brett Hopkins; Hongjun Zhang; Indu Bharathan; Derun Li; Qinglin Pu; Hua Zhou; Theodore A Martinot; Xavier Fradera; Alfred Lammens; Charles A Lesburg; Ryan D Cohen; Jeanine Ballard; Ian Knemeyer; Karin Otte; Stella Vincent; J Richard Miller; Nicolas Solban; Mangeng Cheng; Prasanthi Geda; Nadya Smotrov; Xuelei Song; David Jonathan Bennett; Yongxin Han
Journal:  ACS Med Chem Lett       Date:  2021-08-18       Impact factor: 4.632

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.